Latest / Decera Clinical Education Oncology Podcast
Expert Insights on Highlights From ASH 2020 on Lymphomas/CLL
In this episode, Jeremy S. Abramson, MD, MMSc, discusses highlights of the key data from ASH 2020 on the treatment of patients with lymphomas/CLL, with topics including:
Approved and Investigational Targeted Therapeutics for CLL
Investigational CAR T-Cell Therapy for Indolent Lymphomas, CLL, and Mantle Cell Lymphoma
Bispecific Antibodies and Other Investigational Targeted Agents for Lymphomas
Treatment for Older Patients With Hodgkin Lymphoma
Presenters:
Jeremy S. Abramson, MD, MMSc
Associate Professor
Department of Medicine
Harvard Medical School
Director, Center for Lymphoma
Massachusetts…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.